Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Dr. David Harpole, Duke University Medical Center, details the methods thoracic surgeons use to assess a patient's fitness for surgery.
Transcript
One of the questions that we’re often asked is, “how do thoracic surgeons assess patients’ fitness for surgery?” Interestingly, the old technique that surgeons had before we had pulmonary function studies and so forth was just to get them and walk them up two or three flights of stairs and I still do that occasionally. If a patient’s able to walk up two or three flights of stairs they’re usually fit for a thoracic operation.
However all of our patients now will undergo pulmonary function testing to measure their lung capacity — a test called the diffusion capacity, which tests how well the lung exchanges gases. In other words, when you inhale air how well does your lung take up the oxygen from the air sacs into the blood vessels, and then how well does it release the carbon dioxide from the blood vessels back to the air sacs so you can exhale it out. That test is often the one that’s most predictive of patient’s outcome. Then if a patient has a history of any cardiac disease I will often discuss that with their cardiologist and if necessary, obtain some sort of stress testing and it’s not unusual for us, many of our patients are smokers and many of them have concomitant heart and vascular disease. I would probably say 5% of the time, my patients will have a positive stress test and end up being evaluated by cardiology for interventions before surgery sometimes.
Then we look at the stage of the cancer and if it’s an early stage cancer, we may not obtain any other tests besides routine blood chemistries and so forth. If it’s a more central cancer then we might consider getting head scans and things. I reassure my patients and tell them the likelihood of the cancer having spread to the brain is very unlikely, but we still do it to be safe. Then once that’s been obtained, we’ve gotten a PET scan to assess whether or not the tumor has spread outside the chest. Then we can sit down and discuss what type of operation will be undertaken. For a simple resection or lobectomy that’s usually it; if it’s something that requires more then we may require other testings to measure the impact of the surgery on the patient. If one is taking the entire lung out, that’s certainly a larger operation than taking part of a lung out and so I’ll discuss that with a patient and the possible changes in their lifestyle that may occur with a pneumonectomy, which is the term for removing the whole lung, if that’s required, so that they can fully understand and be fully informed about what they may undergo in the near future.
Please feel free to offer comments and raise questions in our
discussion forums.
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...
Hi Stan! So good to hear from you. I'm sorry for the late response. I too have been out of town with family and missed your post, probably because I was...
It is so good to hear from you! And I am so happy to hear that your holidays have been good and that you are doing well. It sounds like your...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components: